Introducing EyeLib the future of eye health diagnostics

MIKAJAKI is building a better way to diagnose and treat eye healthcare. Using digital technologies, robotics, and artificial intelligence, EyeLib is the first fully automated eye health diagnostic platform on the market.

We’re solving a global healthcare problem.

In today’s aging population, there are tens of millions of individuals requiring eye health diagnosis and treatment. Without enough eyecare professionals to treat them and highly inefficient eye diagnosis and patient care processes, millions of people remain at risk of sight-threatening diseases.

With the launch of EyeLib, MIKAJAKI offers hey health care professionals and patients a fully automated eye diagnostic platform that delivers the most robust eye health analysis available. EyeLib delivers superior care, cost savings, and the capacity to treat millions of people autonomously.

As telemedicine and remote services become new standard in healthcare with the spread of COVID-19, MIKAJAKI is delivering a safer, more affordable, and more efficient eye health diagnostic solution.


We use automation, Artificial Intelligence, and data to drive efficiencies for eyecare professionals, patients, and the healthcare system


EyeLib™ procures comprehensive pre-diagnosis and post-diagnosis services for patients, with minimal interaction required from eye care professionals or staff.

Cost Savings

EyeLib leads to significant cost savings to all stakeholders in the eye healthcare ecosystem. Patients save time, eye professionals streamline patient flow and healthcare providers and insurers eliminate superfluous costs present in current processes.

Advanced Diagnostics

EyeLib advanced diagnostics result in superior reporting capabilities that go far beyond traditional data points and current clinic reporting tools.

Telemedicine Ready

EyeLib™ is practically fully autonomous, which in today's current COVID-19 environment has become a critical feature to enabling patients and eye professionals to work safely and efficiently with minimal contact.

The latest news from MIKAJAKI

Platinn features the MIKAJAKI founders

L’avenir du diagnostic ophtalmologique se joue sous nos yeux

Financial magazine Bilan ranks MIKAJAKI in top 50 Swiss startups

We are happy to inform you that MIKAJAKI was listed in the Swiss economic magazine Bilan as one of the top “50 Swiss Startups in which to Invest in 2020”.

Ready to learn more?

Get in touch with us.